| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A systematic review and meta-analysis of the 2007 WCRF/AICR score in relation to cancer-related health outcomes
|
Solans, M.
|
|
|
31 |
3 |
p. 352-368
|
artikel
|
| 2 |
Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer
|
Moss, J.
|
|
|
31 |
3 |
p. 395-403
|
artikel
|
| 3 |
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
|
Gainor, J.F.
|
|
|
31 |
3 |
p. 404-411
|
artikel
|
| 4 |
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
|
Clarke, N.W.
|
|
|
31 |
3 |
p. 442
|
artikel
|
| 5 |
Corrigendum to Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
|
Mavroudis, D.
|
|
|
31 |
3 |
p. 444-445
|
artikel
|
| 6 |
Corrigendum to Use of skeletal-related events preventive agents in patients with solid tumours and bone metastases in central Denmark
|
Boysen, A.K.
|
|
|
31 |
3 |
p. 443
|
artikel
|
| 7 |
Deep androgen receptor suppression in prostate cancer exploits sexually dimorphic renal expression for systemic glucocorticoid exposure
|
Alyamani, M.
|
|
|
31 |
3 |
p. 369-376
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
31 |
3 |
p. iii
|
artikel
|
| 9 |
Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR
|
Berthold, F.
|
|
|
31 |
3 |
p. 422-429
|
artikel
|
| 10 |
Flawed trials for cancer
|
Tannock, I.F.
|
|
|
31 |
3 |
p. 331-333
|
artikel
|
| 11 |
From astrology to prostate cancer: what is the role of subgroup analyses?
|
Messina, C.
|
|
|
31 |
3 |
p. 437-438
|
artikel
|
| 12 |
Glucocorticoids mediate adverse events of deep androgen receptor axis inhibition in prostate cancer patients
|
Kaochar, S.
|
|
|
31 |
3 |
p. 323-325
|
artikel
|
| 13 |
High-risk neuroblastoma: where do we go?
|
Cañete, A.
|
|
|
31 |
3 |
p. 326-327
|
artikel
|
| 14 |
Interpreting the impact of apalutamide on overall survival among patients with non-metastatic castration-resistant prostate cancer
|
McCaw, Z.R.
|
|
|
31 |
3 |
p. 438-440
|
artikel
|
| 15 |
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification
|
Mazzotta, M.
|
|
|
31 |
3 |
p. 440-441
|
artikel
|
| 16 |
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer
|
Mosele, F.
|
|
|
31 |
3 |
p. 377-386
|
artikel
|
| 17 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, L.-T.
|
|
|
31 |
3 |
p. 334-351
|
artikel
|
| 18 |
Prevalence and mutational determinants of high tumor mutation burden in breast cancer
|
Barroso-Sousa, R.
|
|
|
31 |
3 |
p. 387-394
|
artikel
|
| 19 |
Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breast
|
Di Cosimo, S.
|
|
|
31 |
3 |
p. 435-437
|
artikel
|
| 20 |
Table of Contents
|
|
|
|
31 |
3 |
p. i-ii
|
artikel
|
| 21 |
Targeted therapy for advanced salivary gland carcinoma based on molecular profiling: results from MyPathway, a phase IIa multiple basket study
|
Kurzrock, R.
|
|
|
31 |
3 |
p. 412-421
|
artikel
|
| 22 |
The art of innovation: clinical development of trastuzumab deruxtecan and redefining how antibody-drug conjugates target HER2-positive cancers
|
Yver, A.
|
|
|
31 |
3 |
p. 430-434
|
artikel
|
| 23 |
When are randomized controlled trials needed to assess novel anticancer drugs? An illustration based on the development of selpercatinib, a RET inhibitor
|
Gill, J.
|
|
|
31 |
3 |
p. 328-330
|
artikel
|
Tijdschrift beschrijving